SEC Form 4 · accession 0001567619-19-001255
Zosano Pharma Corp · ZSAN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Linda S Grais
Director
Period of report
Jan 14, 2019
Accepted (ET)
Jan 16, 2019 · 7:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001587221
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.56 | Jan 14, 2019 | A | 25,000 | A | — | Jan 14, 2029 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F125% of the total number of shares underlying the stock option vest on January 14, 2019, and the remaining underlying shares vest in equal monthly installments over the following three-year period.